Q1 2024 Revenue and Business Update
17 avr. 2024 03h05 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, April 17, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today provides an update on its revenue and operational performance for the...
TLX101-CDx (Pixclara™) Granted FDA Fast Track Designation
15 avr. 2024 18h27 HE
|
Telix Pharmaceuticals Limited
FDA Fast Track designation granted for TLX101-CDx for glioma (brain cancer) imagingCollaboration agreement announced for joint development and commercialisation with UCSF PharmaLogic announced as...
World First Use of Lightpoint's SENSEI® Drop-In Gamma Probe in Bladder Cancer Surgery Performed in Spain
26 mars 2024 17h51 HE
|
Telix Pharmaceuticals Limited; Lightpoint Surgical Limited
LONDON, March 27, 2024 (GLOBE NEWSWIRE) -- Lightpoint Surgical Limited (Lightpoint), an affiliate of Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces a world-first...
QDOSE® Platform Partnership for Personalized Dosimetry in Radiopharmaceutical Therapy
18 mars 2024 17h08 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and DRESDEN, Germany, March 19, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has entered into an agreement to...
Appointment of Dr Darren Patti to Group Chief Operating Officer
11 mars 2024 17h31 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, March 12, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) is pleased to announce the appointment of Dr. Darren Patti as Group Chief...
Telix to Acquire ARTMS, Inc. and its Advanced Isotope Production Platform
04 mars 2024 17h42 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, March 05, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has entered into an agreement to acquire radioisotope...
Telix Expands U.S. Development and Manufacturing Infrastructure with Acquisition of IsoTherapeutics
26 févr. 2024 16h27 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has entered into an agreement to acquire IsoTherapeutics...
Telix 2023 Full Year Results: Inaugural Profit Achieved, Strong Revenue Growth Underpins Investment in Late-stage Pipeline
22 févr. 2024 03h51 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces its results for the financial year ended 31 December 2023. All...
Telix Signs Agreement to Acquire QSAM Biosciences and Its Bone Cancer Targeting Platform
07 févr. 2024 16h43 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has entered into an agreement to acquire QSAM Biosciences,...
Telix Highlights Presentations at Upcoming ASCO Genitourinary Cancers Symposium (ASCO GU 2024)
22 janv. 2024 06h00 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces presentations featuring the Company’s theranostic programs at the...